Nervgen Pharma Corp.
- Last sale
- Nov 12, 2026 · +20.00%
- Market cap
- $129.03M
- 79.65M shares
- Filings
- 42
—
—
—FY 2025N/M FY25 yoy
—
—
——
—
—FY 2025N/M FY25 yoy
FY 2025+27.8% FY25 yoy
- $129.03M
- —
- —
- —
- —
- —
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | CA$13,907,206 | reported | |
| FY 2024 | 2024-12-31 | CA$15,811,020 | reported |
Pharmaceutical preparations
Nervgen Pharma Corp. is the 273rd largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
ABEOAbeona Therapeutics Inc.$5.8M—1,223.1%$130.6MMENSJyong Biotech Ltd.———$130.0M
NGENNervgen Pharma Corp. (this company)———$129.0M
ORGOOrganogenesis Holdings Inc.$564.2M17.0%6.6%$125.3MIMUXImmunic, Inc.———$123.9MSPRBSpruce Biosciences, Inc.$0.0100.0%—$123.8MFHTXFoghorn Therapeutics Inc.$30.9M36.8%240.3%$123.5MDERMJourney Medical Corp$61.9M10.2%18.5%$123.4MOKUROnKure Therapeutics, Inc.———$121.7MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Nervgen Pharma Corp. · CIK 1751912 · Engraved from SEC EDGAR